2577 The correlation between circulating cell-free AR and CYP17A1 copy number variations and tumor burden estimated by 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone

2015 ◽  
Vol 51 ◽  
pp. S503-S504
Author(s):  
V. Conteduca ◽  
S. Salvi ◽  
P. Caroli ◽  
E. Scarpi ◽  
C. Lolli ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Copy Number ◽  
Copy Number Variations ◽  
Tumor Burden ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Pet Ct

Testosterone levels and androgen receptor copy number variations in castration‐resistant prostate cancer treated with abiraterone or enzalutamide

The Prostate ◽  
2019 ◽  
Vol 79 (11) ◽  
pp. 1211-1220 ◽  
Author(s):  
Cristian Lolli ◽  
Delia Lisi ◽  
Vincenza Conteduca ◽  
Giorgia Gurioli ◽  
Emanuela Scarpi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Copy Number ◽  
Copy Number Variations ◽  
Castration Resistant Prostate Cancer ◽  
Testosterone Levels ◽  
Castration Resistant

11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel

2015 ◽  
Vol 43 (1) ◽  
pp. 84-91 ◽  
Author(s):  
Francesco Ceci ◽  
Paolo Castellucci ◽  
Tiziano Graziani ◽  
Riccardo Schiavina ◽  
Riccardo Renzi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Castration Resistant Prostate Cancer ◽  
Choline Pet ◽  
Castration Resistant ◽  
Pet Ct

scholarly journals Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone

Oncotarget ◽  
2014 ◽  
Vol 5 (23) ◽  
pp. 12448-12458 ◽  
Author(s):  
Ugo De Giorgi ◽  
Paola Caroli ◽  
Salvatore L. Burgio ◽  
Cecilia Menna ◽  
Vincenza Conteduca ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Outcome Prediction ◽  
Castration Resistant Prostate Cancer ◽  
Early Outcome ◽  
Castration Resistant ◽  
Pet Ct
Sign in / Sign up

Export Citation Format

Share Document